Search

everythinglearnresearchcommunity

for

Search:↓

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Obesity is linked to more severe lower urinary tract symptoms.

Minoxidil increases calcium levels and kills prostate cancer cells independently of calcium.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Finasteride may cause breast enlargement, low testosterone a risk factor.

A new compound that could treat various androgen-related conditions was created and analyzed.

A new compound was made that might help treat diseases related to male hormones.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Bicalutamide may help treat female pattern hair loss.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

The compound was successfully made and shows potential for treating prostate cancer.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Prostate size varies by ethnic group, age, residence, and blood glucose, but not by body measurements or fat.

Patients follow treatment well, but many change medicines; good information helps compliance.

Testosterone significantly affects urination differences between male and female mice.